Conroy Kevin T bought ABT
June 30, 2026 · Form 4 insider transaction
Conroy Kevin T bought 231 shares of Abbott Laboratories at $90.74 per share, a transaction worth $21.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
231
Price
$90.74
Total value
$21.0K
InsiderConroy Kevin T
RoleOfficer, Director
CompanyAbbott Laboratories (ABT)
SecurityStock Equivalent Units
Transaction codeA: Grant or award
Transaction dateJune 30, 2026
Filing dateJuly 1, 2026
Shares owned after231
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.